Phenylbutanoic Acid
Back to searchMolecule Structure
Scientific Name
Phenylbutanoic Acid
Description of the Drug
Phenylbutyric acid is an agent indicated for the adjunctive therapy for the management of chronic urea cycle disorders due to deficiencies in specific enzymes, including the neonatal-onset deficiency and late-onset disease with a history of hyperammonemic encephalopathy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06819
http://www.drugbank.ca/drugs/DB06819
Brand Name(s)
Not Available
Company Owner(s)
Sigmapharm Laboratories Llc, Horizon Therapeutics Llc, Alvogen Inc, Medunik Canada Inc, Par Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glutamine | SMALL MOLECULE | SEQUESTERING AGENT | CHEMBL2366039 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1716 | ||||||
| Human Metabolome Database | HMDB0000543 | ||||||
| DrugBank | DB06819 | ||||||
| PubChem: Thomson Pharma | 15321781 | ||||||
| PubChem | 4775 | ||||||
| Mcule | MCULE-6322732346 | ||||||
| NMRShiftDB | 20200289 | ||||||
| LINCS | LSM-5751 | ||||||
| Nikkaji | J101.512E | ||||||
| PDBe | CLT | ||||||
| BindingDB | 50480960 | ||||||
| EPA CompTox Dashboard | DTXSID2037631 | ||||||
| DrugCentral | 24 | ||||||
| Brenda | 23238 | 49817 | 206444 | 12375 | 31311 | 108441 | 83739 |
| ChemicalBook | CB2385237 | CB5213148 | |||||
| Guide to Pharmacology | 8480 | ||||||
| rxnorm | SODIUM PHENYLBUTYRATE | BUPHENYL | PHENYLBUTYRATE | 4-PHENYLBUTYRIC ACID | |||
| ChEBI | 41500 | ||||||
| ZINC | ZINC000000056568 |
